在COVID-19患者未接种疫苗的住院儿童中,SARS-CoV-2抗体动力学
Dimitra Dimopoulou1, Marietta Charakida1, Antonios Marmarinos2
1From the Second Department of Paediatrics.
The Pediatric infectious disease journal
|February 19, 2024
概括
儿童的COVID-19感染导致持久的抗体反应,严重程度影响抗体水平,而不是年龄. 大多数儿童在感染后的一年内保持可检测的IgG水平,这表明持续的幽默免疫力.
科学领域:
- 免疫学 免疫学 免疫学
- 儿科 儿科 儿科
- 传染性疾病 传染性疾病
背景情况:
- 在急性COVID-19后几个月,抗体水平会下降,但在成年人中,幽默记忆仍然存在.
- 年龄和疾病严重程度等因素可能会影响感染后的抗体反应.
- 了解COVID-19后儿童的抗体耐用性对于评估长期免疫力至关重要.
研究的目的:
- 评估COVID-19住院儿童抗体反应的存在和持久性.
- 评估年龄和疾病严重程度对抗体水平和持续性的影响.
主要方法:
- 对住院治疗COVID-19的未接种疫苗的儿童 (0-16岁) 进行前性,单中心研究.
- 在诊断和感染后的1,3,6和12个月内对抗尖峰SARS-CoV-2IgG和中和抗体进行血清检测.
- 与年龄,感染后的时间和疾病严重程度相关的抗体水平的分析.
主要成果:
- 感染后3个月 (91%),6个月 (85%) 和12个月 (83%) 观察到高血清阳性率.
- 随着时间的推移,SARS-CoV-2 IgG水平显著下降,但不受年龄的影响.
- 较高的疾病严重程度与随访时较低的SARS-CoV-2IgG水平有关.
结论:
- 在儿童中,COVID-19感染诱导了持久的血清转化,可检测的IgG水平持续长达一年.
- 疾病的严重程度,而不是年龄,是影响儿童COVID-19患者抗体标位的重要因素.
- 这些发现表明,在儿童感染SARS-CoV-2后,具有强大而持久的幽默免疫力.
相关概念视频
Pharmacokinetics in Pediatric Patients: Drug Distribution
562
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
562
Pharmacokinetics in Pediatric Patients: Drug Metabolism
417
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
417
Pharmacokinetics in Pediatric Patients: Drug Excretion
414
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
414


